(Reuters) - Analysts had on average expected earnings of 63 cents a
share, according to Reuters Estimates.
Biogen posted net profit of $186 million, or 54 cents a
share, compared to a net loss of $171 million, or 50 cents a
share, a year ago when it took substantial one-time
acquisition-related charges.
Read more at Reuters.com Market News
share, according to Reuters Estimates.
Biogen posted net profit of $186 million, or 54 cents a
share, compared to a net loss of $171 million, or 50 cents a
share, a year ago when it took substantial one-time
acquisition-related charges.
Read more at Reuters.com Market News
No comments:
Post a Comment